Medical Director Emerging Assets & Therapeutic Area Strategy
Johnson & Johnson
Medical Director Emerging Assets & Therapeutic Area Strategy
Johnson & Johnson
Makes prescription drugs and medical devices
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Job Function:
Medical Affairs GroupJob Sub Function:
Medical AffairsJob Category:
People LeaderAll Job Posting Locations:
Toronto, Ontario, CanadaJob Description:
We are searching for the best talent for the Medical Director Emerging Assets & Therapeutic Area Strategy position to join our Medical Affairs team located in Toronto, Ontario, Canada.
About Innovative Medicine
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.
Learn more at https://www.jnj.com/innovative-medicine
Purpose:
The Medical Director Emerging Assets & Therapeutic Area (TA) Strategy provides medical and scientific leadership across both emerging assets and current cross-therapeutic area initiatives within J&J Innovative Medicine Canada. This agile leadership role is accountable for ensuring medical readiness and strategic planning for emerging therapies and supporting current cross-functional therapeutic area capabilities.
The Medical Director, Emerging Assets and TA Strategy serves as the medical lead for emerging portfolio assets prior to their transition into established therapeutic areas, driving medical readiness, evidence generation, and stakeholder engagement strategies that support future growth. The role provides scientific and strategic leadership to internal and external stakeholders while ensuring a seamless transition of assets as they mature.
The Medical Director, Emerging Assets and TA Strategy additionally leads an agile, cross-therapeutic medical team that can be deployed across multiple disease areas to address business priorities, provide specialized expertise, and fill capability gaps. The team supports therapeutic areas during periods of growth and transition while promoting collaboration, consistency, and operational excellence across the medical organization.
The Medical Director, Emerging Assets and TA Strategy is accountable for driving collaboration and alignment across therapeutic areas. They lead the development and execution of national medical education and field medical strategy. The Medical Director leads, coaches, and develops a team that may include Associate Medical Directors, Scientific Advisors, Medical Education, & Medical Science Liaisons in support of both the emerging assets and cross-TA strategy function.
You will be responsible for:
Qualifications / Requirements:
#LI-LGREEN3
#LI-Hybrid
Required Skills:
Preferred Skills:
Data Generation, Developing Others, Healthcare Trends, Inclusive Leadership, Medical Affairs, Medical Communications, Medical Compliance, People Leadership, Stakeholder Collaboration, Strategic ThinkingThe Company uses AI in its assessment of applicants.
This job posting is for an existing position.
Makes prescription drugs and medical devices
Johnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.
Explore more opportunities at Johnson & Johnson